FDA Approves HeartLung’s AI-CVD® for Enhanced Cardiovascular Screening
FDA Grants Approval for HeartLung’s AI-CVD® to Transform Cardiovascular Screening HOUSTON, Jan. 16, 2026 — HeartLung Corporation has…
FDA Grants Approval for HeartLung’s AI-CVD® to Transform Cardiovascular Screening HOUSTON, Jan. 16, 2026 — HeartLung Corporation has…